Boston Scientific Corp (BSX)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 414,000 | 865,000 | 928,000 | 1,925,000 | 1,734,000 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 6,399,000 | 4,933,000 | 3,803,000 | 4,274,000 | 3,681,000 |
| Quick ratio | 0.06 | 0.18 | 0.24 | 0.45 | 0.47 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($414,000K
+ $—K
+ $—K)
÷ $6,399,000K
= 0.06
The quick ratio of Boston Scientific Corp has seen a declining trend over the years, starting at 0.47 on December 31, 2020, and falling to 0.45 on December 31, 2021. However, the ratio experienced a more significant decrease to 0.24 on December 31, 2022, followed by a further decline to 0.18 on December 31, 2023, and a substantial decrease to 0.06 on December 31, 2024. This downward trend indicates a decreasing ability of the company to meet its short-term obligations with its most liquid assets, raising concerns about liquidity and potential difficulties in covering immediate liabilities. Further assessment of the company's financial health and management of working capital may be warranted to address the deteriorating quick ratio.
Peer comparison
Dec 31, 2024